Houston Methodist Research Institute-CCAT Pearland — Pearland, Texas

Houston Methodist Research Institute-CCAT Pearland is a clinical research site located in Pearland, Texas, United States 77584.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Houston Methodist Research Institute-CCAT Pearland has participated in 3 clinical trials.

Therapeutic areas: Heart Failure, Myocardial Infarction, Diabetic Kidney Disease.

Sponsors: Brigham and Women's Hospital, Gilead Sciences, Kowa Research Institute, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pearland

Browse all research sites in Texas · View every site in Pearland

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Houston Methodist Research Institute-CCAT Pearland?

Houston Methodist Research Institute-CCAT Pearland has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Houston Methodist Research Institute-CCAT Pearland conducted?

Houston Methodist Research Institute-CCAT Pearland has 3 clinical trials on record. Their work covers Heart Failure, Myocardial Infarction, Diabetic Kidney Disease.

Is Houston Methodist Research Institute-CCAT Pearland accredited by Crixeo Clinical Trials?

Houston Methodist Research Institute-CCAT Pearland has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Houston Methodist Research Institute-CCAT Pearland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.